Bio3 2024 has adjourned.
The first day of the conference will explore topics around academic entrepreneurship and the essential skills needed to succeed in this area. The morning session will aim to address the challenges of turning research into viable business ventures. Topics will include securing funding, building a team, and balancing academic and business responsibilities. The evening sessions will include keynote presentations followed by round table panel discussions
Stella Taka, Co-founder & CEO, StartBio, Greece (Chair)
Leda Kourita, Physician, Entrepreneur, Investor, USA
Stella Taka, Co-founder & CEO, StartBio, Greece
Stelios Tzannis, CEO Athens LifeTech Park, Greece
Simos Simeonidis, Managing Partner and Co-Founder, Kos Biotechnology Partners, USA
Christina Christodoulou, Communication Coach Speakout, Greece
Georgios Pavlopoulos, Director of Bioinformatics, Research Professor, IFBR - BSRC Alexander Fleming, Greece (Chair)
Welcome Notes
Nikos Kyrpides, Co-founder, BioInnovation Greece & Co-Chair, Bio3 Forum
Zoe Rapti, Deouty Minister for Development, Greece
Tasos Gaitanis, General Secretary for Research and Innovation, Greece
Spyros Artavanis-Tsakonas, Professor Emeritus, Harvard University, USA & Chair, ESETEK, Greece
Stathis Efstathopoulos, Vice Rector of Administrative Affairs & Student Welfare at the University of Athens, Greece
Vaggelis Marinakis, Assist. Professor, National Technical University of Athens & Municipality of Athens, Greece
George Pavlopoulos, Co-founder & Managing Director, BioInnovation Greece Chair, Bio3 Forum
[KEYNOTE] - Spyros Artavanis-Tsakonas, Professor Emeritus, Harvard University, USA & Chair, ESETEK, Greece
Should Greek Biotech care about basic Science
[KEYNOTE] - Eleni Zika, Head of Scientific Impact & Feedback to Policy at European Research Council, Belgium
Impact of science beyond science
Fay Makantasi, Research Director, diaNEOsis, Greece (Chair)
Spyros Artavanis-Tsakonas, Professor Emeritus, Harvard University, USA & Chair, ESETEK, Greece
Eleni Zika, Head of Scientific Impact & Feedback to Policy at European Research Council, Belgium
Aristos Doxiadis, Partner, Big Pi Ventures & Vice-Chair of ESETEK, Greece
Harietta Eleftherochorinou, Vice President, IQVIA Innovation Hub, Greece
Alex Tzoukas, Managing Partner and Co-Founder, Kos Biotechnology Partners, Greece
Konstantinos Drosatos, Professor of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, & President, ARISTEiA Institute, USA (Chair)
Apostolos Gerontas, Historian of Science, Lecturer at Coburg University of Applied Sciences, Germany
Book: Greek Pioneers in Medical and Biomedical Sciences, 1821-2021
Anna Grimani, Author, Journalist, Greece
Book: Πατριδογνωσία - 100 προσωπικότητες αναζητούν την ελληνικότητα
Georgios Miliotis, Lecturer, University of Galway, Ireland (Chair)
[KEYNOTE] - Eleftheria Zeggini, Director, Helmholtz Zentrum Muenchen, Germany
Translational Genomics of Complex Disease
Maria Mirotsou, Vice President, Scribe Therapeutics, USA
Isidore Rigoutsos, Professor, Director, Computational Medicine Center, Thomas Jefferson University, USA
Small RNAs (isomiRs, tRFs, rRFs, yRFs) in diagnosis, prognosis, and therapy of human diseases
Leda Kourita, Physician, Entrepreneur, Investor, USA (Chair)
[KEYNOTE] - Katerina Akassoglou, Senior Investigator, Gladstone Institutes & Professor of Neurology, UCSF, USA
Neuroimmune drivers of neurodegeneration: Translating basic discoveries to the clinic
Nektarios Tavernarakis, Chairman, Board Of Directors at FORTH, Professor, Medical School, University of Crete, Greece
Nucleophagy promotes longevity and preserves germline immortality
Nikos Tapinos, Associate Professor at Brown University & Founder, Tinos Therapeutics
RNA modifications: common regulators of cancer and neurodegeneration
Georgios Miliotis, Lecturer, University of Galway, Ireland
BACTRO-HIT: An engineered for purpose nanoparticle to combat invasive multidrug resistant infections
Georgia Kokaraki, Co-founder of BioInnovation Greece, USA (Chair)
[KEYNOTE] - Kalliopi Trachana, Director, Market Access Illumina, USA
Implementing Precision Medicine in a Health System: A play of Technology, Policy, and Economics
Antonios Tzortzakakis, Senior Consultant in Radiology, Neuroradiology & Nuclear Medicine, Karolinska University Hospital, Sweden
Andreas Massouras, Founder & CEO, Saphetor, Switzerland
Leveraging big data to serve the global genetics community
Stylianos Antonarakis, Professor of Genetic Medicine at the University of Geneva Medical School in Switzerland
Genomic individuality and impact in health
Zoe Cournia, Principle Investigator, BRFAA, Greece (Chair)
Constantinos Deltas, Professor and Director of biobank.cy Center of Excellence, University of Cyprus, Cyprus
Biobanking and the Cyprus Human Genome Project
Ioanna Tzoulaki, Chief Research Scientist, BRFAA, Greece
Uncovering disease pathways through population-based biobanks.
Panagiotis Katsaounis, CEO, Metabio Greece
Digital Biobanking; Pioneering the Next Generation with a focus on Quality Assurance
Fireside Chat: Probiotic Biobanks and the Case for Disease Prevention
George Paraskevakos, Executive Director at International Probiotics Association (Moderator)
Meryl Massot, Project Coordinator and Committee Support chez IPA, Canada
Ioanna Prapa, Molecular Biologist, Democritus University of Thrace, Greece
Stelios Tzannis, CEO, Athens LifeTech Park (Chair)
Maria Denis, CEO, Biomedcode Hellas SA, Greece
Konstantinos Tzortzakis, Co-Founder and CBO Anodyne Nanotech, Inc, USA
Simos Simeonidis, Managing Partner and Co-Founder, Kos Biotechnology Partners, & Chairman of the Board & Co-Founder, Delsona Therapeutics, USA
Alexandra Tolia, VC Investor, Belgium/Greece
On Day 3 a variety of topics in the area of Microbiome innovations will be covered, including microbiome engineering, nutrition in health and microbiome therapeutics.
Nikos Kyrpides, Head, Microbiome Data Science, LBNL, USA (Chair)
David Paez-Espino, Co-Founder & CTO, Ancilia Biosciences, USA
Deciphering and targeting the virome
Nikos Kyrpides, Head, Microbiome Data Science, Lawrence Berkeley National Lab, USA
The Human Gut Virome
Soula Tassou, Research Director ELGO-DIMITRA, Greece (Chair)
George-John Nychas, Emeritus Professor at Agricultural University of Athens, Greece & Distinguished Professor, Shandong Agricultural University, China
Microbiome applications and technological hubs as solutions to minimize food loss and waste
Panagiotis Skandamis, Professor, Agricultural University of Athens, Greece
Soula Tassou, Research Director ELGO-DIMITRA, Greece
Harnessing the potential of microbiome of fermented foods to modulate gut microbiota
Fady Mohareb, Professor, Cranfield University, UK
Bridging the Divide: Uniting Food, Gut Microbiome, and Genotype for Optimal Health
Alexander Rosado, Professor, Biociences, KAUST, Saudi Arabia (Chair)
[KEYNOTE] - Raquel Peixoto, Chair, Marine Science Program and Associate Professor, KAUST, Saudi Arabia
Customized Medicine for Corals and Wildlife
Denise Kelly, Investment Advisor Seventure, Emeritus Professor, UK
Scientific and Commercial advancements in the Microbiome Field - an investor perspective.
Athina Oikonomidou Life Sciences Bus Dev & Tech Transfer Expert, COO ResQ Biotech, Belgium (Chair)
Maira Myrogianni, Secretary General for Greeks Abroad and Public Diplomacy, Greece
Welcome Note
Fireside Chat:
Sophia Kounenaki-Efraimoglou, President of the Athens Chamber of Commerce and Industry, Greece
Angelos Chaniotis, Professor in the School of Historical Studies, Institute for Advanced Study, and President of KOMVOS-NODE, USA
Supporting the Startup Ecosystem:
Aristos Doxiadis, Partner, Big Pi Ventures & Vice-Chair of ESETEK, Greece (Chair)
Maria Goutsou, Partner, Kos Biotechnology Partners, Greece
Lida Kourita, Physician, Entrepreneur, Investor, USA
Greg Roumeliotis, Vice President Of Global Business Development at Orgenesis Inc. Greece
Mike Romanos, Associate Dean for Enterprise, Faculty of Medicine, Imperial College, UK
AI is revolutionizing all aspects of human life, including the development of therapeutics and diagnostics. Day 4 includes sessions that will cover topics in these areas.
Georgios Pavlopoulos, Director of Bioinformatics, Research Professor, IFBR - BSRC Alexander Fleming, Greece (Chair)
Zoe Watson, Co-Founder & CEO, Microvitality, USA &
Sofia Paschenti, Co-Founder & COO, Microvitality, USA
About Microvitality
Maria Georganaki, Director of Product, Intelligencia AI, Greece
Using Physics-Based and Machine Learning Approaches for Efficient Drug Discovery
Stelios Tzannis, CEO Athens LifeTech Park, Greece (Chair)
Stelios Tzannis, CEO, Athens LifeTech Park, Greece
The Impact of Strategic Decision making in Early Drug Development
Vered Caplan, CEO, Orgenesis, USA
Unlocking and Advancing the Value Of Autologous Cell Therapies via Point-Of-Care Manufacturing
Nicolas Christoforou, Head of Cardiology, Alexion Pharmaceuticals / AstraZeneca Rare Disease, USA
Development of Genomic Medicines for the Treatment of Rare Genetic Diseases
Michalis Hadjithomas, Co-founder of BioInnovation Greece (Chair)
[KEYNOTE] - Stavros Papadopoulos, Founder & CEO, TileDB, USA
The AI Database for Multiomics
Vassilis Pitsikalis, Founder, CSO, Deeplab AI, Greece
Grigoris Amoutzias Professor of Bioinformatics Department of Biochemistry and Biotechnology, University of Thessaly, Greece (Chair)
[KEYNOTE] - Theodora Varvarigou, Professor, Computer Science, NTUA, Greece
GenAI on Life Sciences and the Pharmaceutical Sector
Michail Bletsas, Director of Computing, MIT Media Lab, USA
Petros Giannikopoulos, Director, Interventional Genomics Unit, Innovative Genomics Institute, USA
Maria-Christina Grelloni, Head of Growth at Endeavor, Greece (Chair)
heodora Varvarigou, Professor, Computer Science, NTUA, Greece
Michalis Papadakis, Co-founder & CEO, Brainomix, UK
Dimitrios Skaltsas, Co-founder & CEO, Intelligencia AI, USA
Eirini Schlosser, Founder & CEO at Dyania Health
Day 5 will feature discussions and roundtable sessions on the role of various forms of capital in fostering innovation and supporting the development of biotech startups.
Irinna Vavaletskou Palaiologou. Healthcare Portfolio Lead, Endeavor Greece, Greece (Chair)
Dimitrios Adamos, Co-founder and CTO of Cogitat, UK
Ioannis Gkouzionis, Co-founder, Aesthisis Medical, UK
George Eleftheriou, Founder & CEO, Feel Therapeutics, UK
Alexia Polissidis, Co-founder & CEO, Anacalypsis Therapeutics, Greece
Nikos Tapinos, Founder, Tinos Therapeutics, USA
Ioannis Tsamardinos, Co-founder & CSO of JADBio, Greece
Funds and Angel Investors attending:
Stergios Anastasiadis, General Partner, Genesis Ventures, Angel Investor, Greece
Aristos Doxiadis, Partner Emeritus, Big Pi Ventures, Greece
Maria Dramalioti-Taylor, Managing Partner, Beacon Capital, UK
Anta Gkelou, Partner, Sofinnova Partners, France
Nick Kalliagkopoulos, Partner BigPi, Greece
Iraklis Kounadis, Founder, Neweleven Capital, Greece
Georgios Papadopoulos, Angel Investor, Founder of Atypon, USA
Simos Simeonidis, Founder, CEO and CIO, Kos Biotechnology Partners, USA
Andreas Stavropoulos, Partner Threshold Venture, USA
Alex Tzoukas, Managing Partner and Co-Founder, Kos Biotechnology Partners, Greece
Panagiotis Karampinis, Managing Director, Endeavor Greece, Greece (Chair)
Andreas Stavropoulos, Partner Threshold Venture, USA
Simos Simeonidis, Managing Partner and Co-Founder, Kos Biotechnology Partners, & Chairman of the Board & Co-Founder, Delsona Therapeutics, USA
Nick Kalliagkopoulos, Partner BigPi, Greece
Michael G. Gialouris, President & Managing Director ASOFIN Management S.A., Greece
Anta Gkelou, Partner, Sofinnova Partners, France
Maria Dramalioti-Taylor, Managing Partner, Beacon Capital, UK
Konstantinos Drosatos, Professor of Pharmacology & Systems Physiology, University of Cincinnati College of Medicine, & President, ARISTEiA Institute, USA (Chair)
Konstantinos Drosatos, Nikos Kyrpides, Giorgos Nounesis
Theme Introduction
[KEYNOTE] - Mike Romanos, Associate Dean for Enterprise, Faculty of Medicine, Imperial College, UK
Exploiting Bioscience Innovation for Medical and Commercial Impact
Constantine Stratakis, Research Director, Human Genetics & Precision Medicine, FORTH, Greece (Chair)
Ioanna Michalopoulou, Managing Partner, Life Sciences & Medical Technology Attorney at Law, Greece
George Kaliviotis, Vice President and Head of Product Supply, FUJIFILM Diosynth Biotechnologies, USA
Lina Nikolopoulou, Managing Director, MINDVIEW Strategy & Research, Greece
Georgios Papadopoulos, Founder of Atypon & Angel Investor, USA
Sotirios G. Stergiopoulos, President & CEO, A2A Pharmaceuticals, USA (Chair)
Panos Vardas, Professor, Coordinator of Heart Section, Ygeia Hospital Network (HHG), Greece
Alex Tzoukas, Managing Partner and Co-Founder, Kos Biotechnology Partners, Greece
Julia Tseti, President & CEO, UniPharma, Greece
Mata Charokopou, Global Corporate Portfolio Management & Strategy, UCB, Greece
Haris Antoniou, Founder and CEO, Maritime Leasing Ltd, and Codrus Capital AG, & Board Member of KOMVOS-NODE, Greece (Chair)
Anna Panagopoulou, Director, European Research Area & Innovation, European Innovation Center, Belgium
Marianna Nathanail, European Investment Bank (EIB) Institutional Affairs Officer for Greece and Cyprus, Greece
Georgios Antoniadis, Director, Development Banking, Corporate & Investment Banking, Piraeus Bank Group, Greece
Vassilis Paretzoglou, Group Director - Corporate Development, DEMO S.A. Pharmaceutical Industry, Greece
Konstantinos Drosatos, Nikos Kyrpides, Giorgos Nounesis
Structures of Health-Biotechnology-Economy Synergy - Next Steps
BioInnovation Greece
Conference Closing Remarks